文献速递神经MR

成人型弥漫性胶质瘤IDH和CDKN2A/B基因状态的临床可用且可重复的预测模型

Clinically Available and Reproducible Prediction Models for IDH and CDKN2A/B Gene Status in Adult-type Diffuse Gliomas.
PubMed 文献 · Acad Radiol · 2024-06-29

这项回顾性双中心研究纳入272例成人型弥漫性胶质瘤患者,由两名放射科医师独立按VASARI特征集评估影像,用LASSO和多因素logistic回归构建预测IDH突变和CDKN2A/B纯合缺失的模型。IDH突变模型在内外部验证集AUC为0.88-0.96,CDKN2A/B纯合缺失模型AUC为0.80-0.86,决策曲线显示两模型均有良好净获益。

要点

  • 基于VASARI影像特征和临床特征构建的模型可术前预测成人型弥漫性胶质瘤IDH突变和CDKN2A/B纯合缺失。
  • IDH突变预测模型在内外部验证集AUC为0.88-0.96,CDKN2A/B纯合缺失模型AUC为0.80-0.86。
  • 两名放射科医师对VASARI特征的观察者间一致性极好(κ范围0.813-1)。

核心结论

  • 基于VASARI和临床特征的预测模型为弥漫性胶质瘤患者的IDH和CDKN2A/B状态提供了可靠且具有临床意义的术前预测,为成人型弥漫性胶质瘤患者的精准术前无创诊断和个体化治疗提供了基础。

研究设计与样本

  • 回顾性双中心研究,纳入272例成人型弥漫性胶质瘤患者,其中主要队列230例、外部验证队列42例;两名放射科医师独立按VASARI特征集评估影像;采用LASSO回归优化变量选择,多因素logistic回归构建预测模型,并用校准图、ROC曲线和决策曲线分析验证模型,基于预测模型开发列线图。

诊断标准与关键数值

  • IDH突变预测模型在内部和外部验证集的AUC为0.88-0.96。
  • CDKN2A/B纯合缺失预测模型在内部和外部验证集的AUC为0.80-0.86。
  • 两名放射科医师对VASARI特征的观察者间一致性极好,κ范围0.813-1。

临床应用与阅片要点

  • 作者认为基于VASARI和临床特征的预测模型可为弥漫性胶质瘤患者IDH和CDKN2A/B状态提供可靠且具有临床意义的术前预测。
  • 作者认为这些发现为成人型弥漫性胶质瘤患者的精准术前无创诊断和个体化治疗提供了基础。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Isocitrate dehydrogenase (IDH) and cyclin-dependent kinase inhibitor (CDKN) 2A/B status holds important prognostic value in diffuse gliomas. We aimed to construct prediction models using clinically available and reproducible characteristics for predicting IDH-mutant and CDKN2A/B homozygous deletion in adult-type diffuse glioma patients.

MATERIALS AND METHODS: This retrospective, two-center study analysed 272 patients with adult-type diffuse glioma (230 for primary cohort and 42 for external validation cohort). Two radiologists independently assessed the patients' images according to the Visually AcceSAble Rembrandt Images (VASARI) feature set. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to optimise variable selection. Multivariable logistic regression analysis was used to develop the prediction models. Calibration plots, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA) were used to validate the models. Nomograms were developed visually based on the prediction models.

RESULTS: The interobserver agreement between the two radiologists for VASARI features was excellent (κ range, 0.813-1). For the IDH-mutant prediction model, the area under the curves (AUCs) was 0.88-0.96 in the internal and external validation sets, For the CDKN2A/B homozygous deletion model, the AUCs were 0.80-0.86 in the internal and external validation sets. The decision curves show that both prediction models had good net benefits.

CONCLUSION: The prediction models which basing on VASARI and clinical features provided a reliable and clinically meaningful preoperative prediction for IDH and CDKN2A/B status in diffuse glioma patients. These findings provide a foundation for precise preoperative non-invasive diagnosis and personalised treatment approaches for adult-type diffuse glioma patients.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu M, Han F, Gao J, et al. Clinically Available and Reproducible Prediction Models for IDH and CDKN2A/B Gene Status in Adult-type Diffuse Gliomas. Acad Radiol. 2024. PMID: 38944632. doi:10.1016/j.acra.2024.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。